82 Biggest Movers From Yesterday
Gainers
Comera Life Sciences Holdings, Inc. (NASDAQ: CMRA) gained 126.5% to settle at $2.65 on Tuesday.
Here’s How Citi Views Amylyx Pharma
Citi Research has raised the price target on Amylyx Pharmaceuticals Inc’s (NASDAQ:AMLX) to $33 from $32, with a Buy rating. It says the…
Canada Approves Amylyx’s ALS Drug; FDA To Consider Approval In September
The Canadian government has given its approval to AMX0035, a new drug from Cambridge, Massachusetts-based Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Announces Health Canada Approval Of ALBRIOZA For The Treatment Of ALS
Health Canada decision signifies the first global regulatory approval for Amylyx and the first new therapy for ALS approved in Canada since 2018
ALBRIOZA (also known as AMX0035) is an oral fixed-dose
83 Biggest Movers From Yesterday
Gainers
Symbotic Inc. (NASDAQ: SYM) shares surged 120.6% to settle at $20.07 on Wednesday. Symbotic reported the completion of its business combination with SVF Investment Corp. to become a publicly traded company.
69 Biggest Movers From Friday
Gainers
Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per share.
Mid-Afternoon Market Update: Gold Drops 1%; Sprague Resources Shares Spike Higher
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping more than 300 points on Friday.
Amylyx Pharmaceuticals Shares Shoot Up As FDA Extends Review Of NDA For Neurodegenerative Disease Candidate
The U.S. Food and Drug Administration (FDA) has extended the review of New Drug Application (NDA) by three months, submitted by Amylyx Pharmaceuticals (NASDAQ: AMLX) for its lead drug candidate AMX0035 with regard to the treatment of patients with amyotrophic lateral sclerosis (ALS).
Mid-Day Market Update: Nasdaq Down 300 Points; Turning Point Therapeutics Shares Jump
U.S. stocks extended losses midway through trading, with the Nasdaq Composite dropping more than 300 points on Friday.
40 Stocks Moving In Friday’s Mid-Day Session
Gainers
Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares jumped 115.8% to $73.72 after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per share.